Parenteral Drug Association
Connecting People, Science and Regulation
®
Home
Events & Training
Topic Areas
Aseptic Processing & Sterilization
Biopharmaceuticals & Biotechnology
Manufacturing Science
Quality & Regulatory
Supply Chain & Outsourcing
Publications
Bookstore
PDA Journal
PDA Letter
Technical Reports
Global Community
Chapters
Interest Groups
Membership Directory
Member Resources
PDA Connect
Standards
Volunteer Opportunities
Join PDA
NOVAVAX INVESTOR RELATIONS
Follow
Share
Articles
Products
By Novavax Investor Relations - Aug 15 2022
Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older
If authorized, Novavax' vaccine would be the first protein-based COVID-19 booster for adults If authorized, the Novavax COVID-19 Vaccine,...
Website:
ir.novavax.com
